Simranjit X Singh

Years Active: 2019-2022
Publications (10 Years): 3

NYU Langone Health

Duke University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NYU Langone Health Oct 01 2015 - Jun 01 2017

United States

Research Technician/Lab Manager :: Pathology

Education History

Duke University School of Medicine Sep 01 2017

United States

PHD :: Pathology

Publications

Simranjit X Singh, Rui Yang, Kristen Roso, Landon J Hansen, Changzheng Du, Lee H Chen, Paula K Greer, Christopher J Pirozzi, Yiping He
Purine Synthesis Inhibitor L-Alanosine Impairs Mitochondrial Function and Stemness of Brain Tumor Initiating Cells. Biomedicines 10 (4) (2022)
Changzheng Du, Steven W Li, Simranjit X Singh, Kristen Roso, Michael A Sun, Christopher J Pirozzi, Rui Yang, Jian-Liang Li, Yiping He
Epigenetic Regulation of Fanconi Anemia Genes Implicates PRMT5 Blockage as a Strategy for Tumor Chemosensitization. Molecular cancer research : MCR 19 (12) (2021)
Landon J Hansen, Ran Sun, Rui Yang, Simranjit X Singh, Lee H Chen, Christopher J Pirozzi, Casey J Moure, Carlee Hemphill, Austin B Carpenter, Patrick Healy, Ryan C Ruger, Chin-Pu J Chen, Paula K Greer, Fangping Zhao, Ivan Spasojevic, Carole Grenier, Zhiqing Huang, Susan K Murphy, Roger E McLendon, Henry S Friedman, James E Herndon, John H Sampson, Stephen T Keir, Darell D Bigner, Hai Yan, Yiping He
MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation. Cancer research 79 (13) (2019)

Simranjit X Singh.css-eqlu8i{font-size:small;padding-left:4px;}